Please login to the form below

Not currently logged in
Email:
Password:

Heron Therapeutics

This page shows the latest Heron Therapeutics news and features for those working in and with pharma, biotech and healthcare.

FDA awards another non-opioid pain drug breakthrough status

FDA awards another non-opioid pain drug breakthrough status

Concentric specialises in novel non-opioid pain therapeutics, and CA-008 is a first-in-class non-opioid therapeutic that rapidly converts to capsaicin, a potent TRPV1-agonist. ... The announcement follows a BTD in June for Heron Therapeutics and its

Latest news

  • Heron boosted by new data for ‘breakthrough’ pain drug Heron boosted by new data for ‘breakthrough’ pain drug

    for postoperative pain management, in phase III studies,” said Barry Quart, Heron’s chief executive. ... March that Exparel sales would fall off dramatically if HTX-011 is approved – particularly as she thinks Heron’s drug is likely to be cheaper.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Random42 Scientific Communication

    Boston Biomedical. Boston Scientific . Bristol-Myers Squibb. BTG. Celgene. Ceva. Chiesi. Cidara Therapeutics. ... Genentech. Genzyme. Gilead. Grunenthal. GlaxoSmithKline. HCA Healthcare. Heron Therapeutics. Ignyta. Ironwood.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics